ovulation induction congenital malformations risk, clomiphene fertility drugs birth defects, ovulation stimulation teratogenicity, Harlap ovulation induction malformations, fertility treatment congenital anomalies 1976, ovulatory drugs fetal abnormalities, assisted reproduction birth defect risk, pharmacological ovulation induction safety, infertility treatment pregnancy outcomes malformations, gonadotropin therapy congenital defects
PMID 62185 62185 DOI 10.1016/s0140-6736(76)90921-1 10.1016/s0140-6736(76)90921-1
Keywords
Abnormalities, Drug-Induced/epidemiology, Clomiphene/adverse Effects/therapeutic Use, Female, Humans, Infant, Newborn, Infertility, Female/drug Therapy, Pregnancy, Clomiphene